Metropolis, IPCA & PCI:Fight Malaria-Making It Possible

Published on Sat, Apr 26, 2008 at 16:21 |  Source : Moneycontrol.com

Updated at Sat, Apr 26, 2008 at 17:09  

4680 Investors following Ipca Labs. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Commemorating the world's first ever World Malaria Day, three leading companies-Metropolis Health Services, Ipca Laboratories and Pest Control India-from different arenas, yet bound by a common objective of defeating malaria, on Friday, joined hands to form Fight Malaria - Making It Possible. The primary objective of the foundation is to spread awareness of the disease, help control the problem and provide expert solutions to control and fight the menace.

 

The companies involved in the mission to make this possible are leaders in providing anti-malarial solutions across 3 different arenas of providing leading pest management, expert diagnostics and anti-malarial drugs, hence forming a unique 360 degree approach in tackling the menace.  Metropolis is a leading corporatised diagnostic firm since 1981, Ipca Laboratories is the market leader in anti malarial drugs in India since 1975 and PCI is a leading pest management company since 1954. The tagline, "Making It Possible", was derived from the initials of each company.

 

The respective spokespersons of the three organizations were ecstatic to share the foundation day of the association with the first ever World malaria day, a day incorporated to provide effective control and measures of malaria around the world.

 

On this occasion Dr Sushil Shah, Chairman, Metropolis Health Services, said "World over this is the first time ever the anti malaria day will be celebrated and we are proud to be part of this mission. We were finding ways and coming up with something unique and different on this day, hence we choose to form an association exclusively for malaria. We are indeed delighted and honored to be part of this mission which will not only help save lives but will also promote wellness in our society. Through our foundation we wish to enhance awareness about cause, prevention & treatment among the target communities and healthcare service providers through information, communication and education"

 

Mr. Premchand Godha, Managing Director, IPCA Laboratories commented, "Ipca is committed to tackle the global menace of Malaria. For this, we are launching global Mission Malaria and a separate Marketing division at the domestic level. We are the biggest manufacturers of anti malarial APIs and Formulations in India and also the market leader. We are committed to offering effective and affordable antimalarial therapies. To combat resistance, WHO recommends Artemisinin-based Combination Therapies (ACTs) and one of the key challenges is ensuring continued supply of artemisinin which is an agricultural product. To reduce dependence on imports, Ipca is already growing the crop in many states. Ipca has also undertaken backward integration by manufacturing of APIs. We also have strong partnerships with CIMAP and CDRI for New Anti malarial Drug Development. Our plants for APIs and Formulations are approved by major regulatory authorities like WHO-Geneva USFDA, UK MHRA, TGA - Australia, MCC - South Africa etc. We are proud to be part of this joint initiative and are open for more such collaborations across the world." 

 

Adding further Nikhil Chatterjee, Vice President-Marketing, PCI said "Today, malaria has become a global problem resulting to over one million deaths each year. Malaria exacts a serious toll of illness and death amongst pregnant women and children who are largely affected with the problem. As specialists in the field of pest management and in business for more than half a century we know that only an integrated approach can effectively tackle the mosquito menace. An integral aspect of all operations is the initiative and co-operation of local residents through awareness programmes. We aim to control the mosquito menace through operations to be undertaken in small industrial towns, townships, housing colonies, villages and major cities in different parts of the country. Through our mission we yearn to reduce malaria transmission, provide adequate relief to the affected population, prevent further spread of the epidemic and develop sustainable malaria research capacity through partnerships with experts from various fields."

 

Sourced From: Blue Lotus Communications Pvt. Ltd

  

Trending News

Business News

Sony to roll-out ICS update next week, Xperia PLAY gets the boot
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

Live Updates: CSK keep KKR under the pump

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!